Glaukos (GKOS) Cash & Equivalents (2013 - 2026)

Glaukos (GKOS) has 14 years of Cash & Equivalents data on file, last reported at $104.2 million in Q1 2026.

• Quarterly Cash & Equivalents fell 8.76% year-over-year to $104.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $104.2 million (down 8.76% YoY) and the FY2025 annual result came in at $90.8 million, down 46.46% from the prior year.
• Cash & Equivalents improved to $104.2 million in Q1 2026 per GKOS's latest filing, from $90.8 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $169.6 million in Q4 2024 and bottomed at $42.5 million in Q1 2024.
• The 5-year median for Cash & Equivalents is $100.8 million (2025), against an average of $99.7 million.
• Peak annual rise in Cash & Equivalents reached 168.86% in 2025, while the deepest fall reached 46.46% in 2025.
• Tracing GKOS's Cash & Equivalents over 5 years: stood at $119.5 million in 2022, then decreased by 21.8% to $93.5 million in 2023, then surged by 81.48% to $169.6 million in 2024, then slumped by 46.46% to $90.8 million in 2025, then rose by 14.8% to $104.2 million in 2026.
• Per Business Quant, the three latest GKOS Cash & Equivalents figures stand at $104.2 million (Q1 2026), $90.8 million (Q4 2025), and $98.2 million (Q3 2025).

Peer Comparison